πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 59 of 200 Β· A–Z by INN

  1. dorzolamide

    TRUSOPT Alphapharm Pty Ltd

    TGA: approved

  2. dorzolamide + timolol

    COSDOR Alphapharm Pty Ltd

    TGA: approved

  3. dorzolamide hydrochloride

    DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE Regeneron Ireland Designated Activity Company (DAC)

    OPHTHALMIC FDA: approved

  4. dose

    NMPA: clinical trials

  5. dose-escalation

    NMPA: clinical trials

  6. dostarlimab

    JEMPERLI GlaxoSmithKline

    EMA: approved Β· TGA: approved

    L01FF07
  7. dostarlimab-gxly

    JEMPERLI

    INJECTION FDA: approved

  8. dosulepin

    DOSULEPIN VIATRIS Alphapharm Pty Ltd

    TGA: approved

  9. doxacurium chloride

    NUROMAX

    INJECTION FDA: approved

  10. doxapram

    NMPA: clinical trials

  11. doxapram hydrochloride

    DOXAPRAM HYDROCHLORIDE

    INJECTION FDA: approved

  12. doxazosin mesylate

    CARDURA Teva Pharma GmbH

    ORAL FDA: approved

  13. doxecitine

    KYGEVVI

    ORAL FDA: approved Β· EMA: approved

    A16AX29
  14. doxepin hydrochloride

    DOXEPIN HYDROCHLORIDE Amneal Pharma Europe Ltd

    TOPICAL FDA: approved

  15. doxercalciferol

    DOXERCALCIFEROL Amneal Pharma Europe Ltd

    INJECTION FDA: approved

  16. doxil

    NMPA: clinical trials

  17. doxorubicin

    ADRIAMYCIN Pfizer Australia Pty Ltd

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01DB
  18. doxorubicin hydrochloride

    CELDOXOME PEGYLATED LIPOSOMAL Amneal Pharma Europe Ltd

    INJECTION FDA: approved Β· EMA: unknown

    L01DB01
  19. doxorubicin hydrochloride (as pegylated liposomal)

    CAELYX BAXTER HEALTHCARE PTY LTD

    TGA: approved

  20. doxorubicin hydrochloride liposome+irinotecan

    NMPA: clinical trials

  21. doxorubicin-group

    NMPA: clinical trials

  22. doxycycline

    APX-DOXYCYCLINE Alphapharm Pty Ltd

    ORAL FDA: approved Β· TGA: approved Β· NMPA: clinical trials

  23. doxycycline calcium

    VIBRAMYCIN

    ORAL FDA: approved

  24. doxycycline hyclate

    DOXYCYCLINE HYCLATE Amneal Pharma Europe Ltd

    INJECTION FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources